ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 1161 for:    chelation

Chronic Lymphocytic Leukemia Responds to Dermal Chelation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03495492
Recruitment Status : Not yet recruiting
First Posted : April 12, 2018
Last Update Posted : April 12, 2018
Sponsor:
Information provided by (Responsible Party):
Optimum Health, Natural Healthcare Center

Brief Summary:
The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

Condition or disease Intervention/treatment Phase
Chronic Lymphocytic Leukemia Device: Dermal Chelation Dietary Supplement: Nutritional Therapy Not Applicable

Detailed Description:
The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Clinical trials with a single arm
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Dermal Chelation Lowers White Blood Cell Count in Chronic Lymphocytic Leukemia
Estimated Study Start Date : December 1, 2018
Estimated Primary Completion Date : March 1, 2019
Estimated Study Completion Date : March 1, 2019


Arm Intervention/treatment
Experimental: Participants
Group receiving dermal chelation and nutritional therapy
Device: Dermal Chelation
Dermal chelation with Aqua DetoxTM system for one or more hours one or more times each week.
Dietary Supplement: Nutritional Therapy
Vitamins and minerals that will be taken one or more times a day.



Primary Outcome Measures :
  1. Serial Total White Blood Cell Count [ Time Frame: up to 12 months ]
    Total WBC counts taken on a regular interval.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load
  • Toxic heavy metal load

Exclusion Criteria:

  • Pregnant
  • Pacemaker implants
  • Organ transplant recipients
  • Psychotic episodes or epileptic seizures

Additional Information:
Publications of Results:

Other Publications:
Responsible Party: Optimum Health, Natural Healthcare Center
ClinicalTrials.gov Identifier: NCT03495492     History of Changes
Other Study ID Numbers: DCCLL2018
First Posted: April 12, 2018    Key Record Dates
Last Update Posted: April 12, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No

Keywords provided by Optimum Health, Natural Healthcare Center:
Chronic Lymphocytic Leukemia
CLL
Dermal Chelation
Nutritional Therapy

Additional relevant MeSH terms:
Leukemia
Leukemia, Lymphoid
Leukemia, Lymphocytic, Chronic, B-Cell
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Leukemia, B-Cell